Super-Resolution Approaches for Capturing Cellular Dynamics

Autologous cell therapy products are patient-specific therapies that use cells harvested from a single patient to treat that same patient. Final product release tests that require minimal sampling, produce rapid valid results, and are inexpensive to use is critical because each lot of final product requires testing prior to implantation in the patient.

The ability to interpret data is crucial to advancing cell and gene therapy research. But raw data is rarely useful when it comes to gleaning insights.

As it is with so many things in life, how we begin often sets the tone for the entire journey. Bioproduction endeavors are no different. Using robust reagents and developing reproducible procedures at the early stages of your bioprocess is critical to producing a safe and efficacious final product. Upstream process scientists are constantly trying to improve parameters such as growth conditions, media analysis, and optimizing cell lines to ease the burden on downstream purification steps. Determining the best way to begin your bioproduction journey takes a lot of experience and can often seem daunting. However, in this presentation, our panelists will tell us what’s necessary for those initial successful steps.

Mixed Reality (MR) also known as “hybrid reality” and “extended reality,” has the potential to change just about every industry, healthcare being no exception. A combination of Virtual Reality (VR), Augmented Reality (AR), and Artificial Intelligence (AI); MR is emerging as a tech to create experiences that blend the real-life environment with digital elements.